of the diet-within the ranges recommended by different guidelines-with metabolic risk factors. Methods We studied 1785 people with type 2 diabetes, aged 50-75, enrolled in the TOSCA.IT Study. Dietary habits were assessed using a validated food-frequency questionnaire (EPIC). Anthropometry, fasting lipids, HbA1c and C-reactive protein (CRP) were measured. Results Increasing fat intake from <25 to ≥35 % is associated with a significant increase in LDL-cholesterol, triglycerides, HbA1c and CRP (p < 0.05). Increasing carbohydrates intake from <45 to ≥60 % is associated with significantly lower triglycerides, HbA1c and
Introduction
The medical nutrition therapy is a cornerstone in the treatment of diabetes; the main goal is to improve glucose control and the cardiovascular risk factors profile [1, 2] . Whereas it is well established that caloric restriction ameliorates glucose control and the plasma lipids profile, mainly through weight loss [3] , the optimal macronutrient composition of the diet for the management of patients with type 2 diabetes is still debated. A high protein intake is generally not recommended for patients with diabetes [4] . Therefore, the macronutrient composition of the diet is mainly regulated by the carbohydrate-to-fat ratio, but the ideal proportion of these main food components that should be recommended remains controversial [5] [6] [7] [8] [9] [10] . The British Diabetes Association, European Association for the Study of Diabetes (EASD), American Diabetes Association (ADA), American Heart Association, Canadian Diabetes Association, International College of Nutrition, groups from South Africa and Japan, and the National Cholesterol Education Panel (Adult Treatment Panel 3) have slightly different recommendations for the optimal diet in people with type 2 diabetes [11] [12] [13] [14] [15] [16] . The recommended intake of fat ranges from <25 to 35 % of total energy intake, whereas the recommended carbohydrates intake varies from 45 to 60 % [17] . Restriction of added sucrose or fructose to a maximum of 10 % of the total energy intake, and fiber intake between 20 and 35 g/day are generally recommended. The importance of quality of specific macronutrients and individualized dietary goals is generally emphasized.
One major criticism to these guidelines is that there is insufficient evidence to justify the recommendations. Studies designed to compare the metabolic effects of the various dietary approaches suggested by different organizations for diabetes management are lacking. In particular, the metabolic effects of diets with different proportions of fat and carbohydrates-within the ranges recommended by the nutritional guidelines-have not been explored. Expanding knowledge on this topic would be relevant to help clinicians in the choice of the most suitable dietary intervention(s) to improve the metabolic and cardiovascular risk factors profile in people with diabetes.
The aim of the study is to characterize the habitual diet of a large cohort of people with type 2 diabetes and to explore, in real-life clinical practice, the association of different proportions of fat and carbohydrates of the dietwithin the ranges recommended by different authoritieswith metabolic risk factors. The association of fiber and added sugar with metabolic risk factors is also analyzed.
Materials and methods
We studied 1785 men and women with type 2 diabetes, aged 50-75 years, enrolled in the TOSCA.IT Study, a randomized clinical trial (clinicaltrials.gov NCT00700856) designed to compare the impact of glucose lowering drugs on cardiovascular event. For the purposes of the present analysis, we used baseline data, collected prior to randomization to study treatment. The study protocol has been approved by the Ethics Review Committee of the coordinating center and of each participating center; written informed consent was obtained from all participants. The details of the study protocol have been published [18] . Body weight, height, waist and hip circumference were measured according to a standard protocol. Body mass index (BMI) was calculated as weight (kg)/height (m 2 ). Biochemical analyses were performed in a central laboratory on fasting samples. Total cholesterol, HDL-cholesterol and triglycerides were measured by standard methods. LDL-cholesterol was calculated according to the Friedewald equation [19] for people with triglycerides values <400 mg/dl. HbA1c
was measured with high-performance liquid chromatography (HPLC), and high-sensitivity C-reactive protein (CRP) was measured by Tina-Quant on Roche/Hitachi 904. At the time of the study, all patients were treated with metformin only: 62 % were on lipid-lowering medications and 90 % were on antihypertensive drugs.
The dietary habits were assessed with the Italian version of the European Prospective Investigation into Cancer and Nutrition (EPIC) questionnaire [20, 21] . The questionnaire contains 248 items including the type of fat used as condiment, or added after cooking. The respondent indicates the absolute frequency of consumption of each item (per day, week, month or year). The quantity of the food consumed was assessed on the basis of the respondent's selection of an image of a food portion showing a small, medium and large portion size, with additional quantifiers (e.g., "smaller than the small portion" or "between the small and medium portion"). The nutrient composition of the diet, the glycemic index and the glycemic load were calculated with the use of a software containing the Italian Food Tables [22, 23] and the International Tables of Glycemic Index [24] . Incomplete questionnaires and questionnaires with implausible data (i.e., energy intake <800 or >5000 kcal/day) were excluded from the analyses.
Statistical analysis
Data are given as mean and standard deviation or number and proportion, as appropriate. Not normally distributed variables were logarithmically transformed for statistical analyses and back-transformed into natural units for presentation in text and tables. For analytical purposes, Added sugar (% of energy) 2.9 ± 3.9 the dietary intake of the macronutrients of interest was divided into arbitrary categories which reflect the cutoff points derived from different nutritional recommendations (reviewed in [17] ), that is, <25 %, 25-34 % or ≥35 % for total fat intake; <45 %, 45-59 % or ≥60 % for CHO; <10, 10-14 or ≥15 g/1000 kcal for fiber and <5 %, 5-9 % or ≥10 % for added sugar. Plasma lipids, HbA1c and CRP were analyzed across categories of fat, CHO, fiber intake and added sugar by analysis of variance (ANOVA) with post hoc test (Bonferroni). Adjustment for covariates was performed with the general linear model (ANCOVA). The statistical significance was defined as p < 0.05, two sided. All statistical analyses were performed with the SPSS software for Windows, version 20.0. Table 1 gives the clinical characteristics of the study participants along with the composition of the diet and the [17] . On average, the study participants are overweight/obese, 75 % have abdominal obesity (i.e., waist circumference above 102 cm for men, or 88 cm for women) [16] . The glucose control and the plasma lipids profile are close to the treatment targets recommended by the Italian standards of care for people with type 2 diabetes [25] . The energy intake is high (1898 ± 673 kcal) considering the elevated BMI. The total and saturated fat content of the diet is slightly above recommended. The average carbohydrates content is in the low recommended range (45.1 ± 7.2 % of total energy); the glycemic index is low (51.7 ± 3.3 %), which suggests that the carbohydrates of the diet are largely represented by slowly absorbable carbohydrates. The fiber intake is lower than recommended (19.4 ± 2.7 g/day). As expected, the energy intake is directly associated with plasma triglycerides and inversely associated with HDLcholesterol; no association with LDL-cholesterol, HbA1c and CRP was observed (data not shown). In order to correct for the effect of energy intake in further analyses, the intake of fat, carbohydrates and added sugar is expressed as proportion (%) of the total energy of the diet and the intake of dietary fiber is expressed as g/1000 kcal/day.
Results
The increase in fat intake from <25 to 35 % or more is associated with a significant increase in LDL-cholesterol, triglycerides, HbA1c and CRP (p < 0.05 for all) with a significant linear trend (Table 2) . To the contrary, increasing carbohydrates intake from <45 to 60 % or more is associated with significantly lower triglycerides, HbA1c and CRP (p < 0.05 for all), whereas no changes are observed for LDL-or HDL-cholesterol (Table 2) .
A consumption of fiber ≥15 g/1000 kcal is associated with significantly lower triglycerides, HbA1c and CRP, and higher HDL-cholesterol, compared with a fiber intake <10 g/1000 kcal (Table 3) . To the contrary, plasma triglycerides, HbA1c and CRP increase progressively and significantly with the increasing consumption of added sugar, whereas no effect is observed for LDL-or HDL-cholesterol (Table 3) .
The proportion of study participants on lipid-lowering agents is not significantly different across the categories of the nutrients intakes considered (Tables 2, 3) . A sensitivity analysis, conducted with the exclusion of people on hypolipidemic drugs confirmed the findings (Tables 4, 5 ).
Discussion
Although central to medical nutrition therapy, the association of dietary approaches with different proportions of fat and carbohydrates and metabolic risk factors in patients with type 2 diabetes has been little explored. The only meta-analysis which has been performed to quantify the probable metabolic effects of different fat and carbohydrates proportions in people with diabetes was based on intervention studies conducted in small groups of selected patients [5] . Some of the dietary approaches tested included a carbohydrates content as high as 75 % and a fat content as low as 10 % which are out of the recommend ranges for people with diabetes and are also difficult to adhere with in the long term. In addition, studies investigating highcarbohydrates diets also high in dietary fiber were excluded from this analysis [5] . To our knowledge, the present study is the first to characterize the habitual diet of a large cohort of people with type 2 diabetes and to explore, in real-life clinical practice, the association of different proportions of dietary fat and carbohydrates with metabolic risk factors.
The study shows that relatively small variations in the proportion of fat and carbohydrate-within the ranges recommended by most organizations (reviewed in [17] )-are significantly associated with metabolic risk factors and low-grade inflammation, independent of energy intake and use of hypoglycemic drugs. The increase in fat intake from <25 to ≥35 % is associated with a significant increase in LDL-cholesterol, triglycerides, HbA1c and CRP, whereas the increase in carbohydrates intake from <45 to ≥60 % is associated with significantly lower triglycerides, HbA1c and CRP.
The optimal proportion of fat and CHO of the diet for the management of diabetes is debated [5] [6] [7] [8] [9] [10] . Most, though not all, studies show that low-fat/high-carbohydrates diets have a negative impact on plasma triglycerides, HDL-cholesterol, insulin resistance and glucose control [10, [26] [27] [28] . The inconsistent findings can be partly explained by differences in the design and analysis of these studies. The lack of standard definitions for high (low)-fat and high (low)-carbohydrates diet makes it difficult to compare different studies. Furthermore, correction for energy intake is not always performed and the source and quality of carbohydrates is rarely taken into account.
In our study population, the main source of carbohydrates is represented by slowly absorbable carbohydrates, as suggested by the low glycemic index of the diet. These characteristics may largely account for the lack of detrimental associations of high carbohydrates consumption with plasma lipids, glucose control and low-grade inflammation. In line with this hypothesis, we find that increasing the intake of fiber is associated with lower triglycerides and CRP and higher HDL-cholesterol levels, whereas the increase in the consumption of added sugars is associated with significantly higher plasma triglycerides, higher CRP and lower HDL-cholesterol. These findings are quite new; whereas the association of dietary fiber with LDL-cholesterol has been extensively investigated, little information 1 3 exists on triglycerides, HDL-cholesterol levels and markers of low-grade inflammation.
Although small in magnitude, the observed metabolic changes are coherent with the results of lifestyle interventions studies [29, 30] and, if translated at the population level, may significantly impact on the population's absolute cardiovascular risk.
The large study population representative of the general diabetic population commonly seen in real-life clinical practice and the central measurement of the metabolic variables (plasma lipids, HbA1c, CRP) are the major study strengths. Among the study limitations, we must acknowledge the observational design and the extensive use of hypolipidemic drugs which, although equally distributed across categories of nutrients intake, may have partly offset the quantitative effect of nutritional factors. However, a sensitivity analysis, performed after exclusion of people on hypolipidemic drugs, confirmed the results, thus strengthening the findings.
In summary, the study shows that in people with type 2 diabetes, changes in the proportion of fat and CHO of the diet within the relatively narrow ranges proposed by different authorities are associated with significant changes of the metabolic profile and low-grade inflammation The study provides strong observational data in support of the potential for reducing dietary fat intake and added sugars, preferring complex, slowly absorbable, carbohydrates in the habitual diet for patients with type 2 diabetes.
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